share_log
Reuters ·  May 7 03:49
Stoke Therapeutics Inc : Canaccord Genuity Cuts Target Price to $20 From $21
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment